STOCK TITAN

IDenta (IDTA) Stock News, Mar 2022-May 2024

IDTA OTC

IDenta Corp. (IDTA) develops and supplies rapid field detection, home diagnostic testing, and forensic identification products for narcotics, drugs, explosives, homeland security, law enforcement, and consumer markets. Company news centers on periodic financial results, profitability, cash position, working capital, inventory, customer activity, and product delivery for government agencies, law enforcement organizations, distributors, and other global customers.

Recurring updates also cover market expansion, distributor relationships, operational efficiency, product development, and shareholder meeting or governance matters tied to the company's public-company structure.

Rhea-AI Summary

IDenta Corp (OTCQB: IDTA), a leader in Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives, and Forensic Products, reported a substantial improvement in its first quarter of 2024 financial results.

First Quarter 2024 highlights include revenues of $428,346, up from $231,623 in Q1 2023, and a gross profit increase to $354,118 from $179,482 in the same period. Operating profit soared to $176,067 compared to a loss of $45,375 in Q1 2023, while net profit reached $171,010, recovering from a loss of $25,554. Cash and cash equivalents also rose to $336,192 from $264,294 year-over-year.

CEO Amichai Glattstein attributed the success to expanded distribution, customer growth, and optimized production, positioning the company for sustained future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
133.94%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
-
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) reported its 2022 annual financial results, highlighting a sharp increase in net profit to $162,711, a 240% rise from 2021. This was driven by enhanced currency exchange rates and management efficiency. However, revenue declined by 4% to $1,338,754, with gross profit increasing by 5% to $1,123,021 due to production optimization. Operating profit fell 71% to $125,316, linked to costs from trade shows and production expansions. Cash reserves slightly rose to $368,901. CEO Amichai Glattstein emphasized a focus on the US market and product exposure as key growth strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA), a leader in developing field detection and home diagnostic testing kits, reported its 2022 third quarter financial results on November 15, 2022. Key highlights include a 31% increase in gross profit to $287,451 and a significant turnaround in operating profit to $19,870 from a loss of $12,177 the previous year. Net profit rose to $19,419 from a loss of $45,792. However, cash and cash equivalents fell to $324,475 from $347,151 year-over-year. The CEO emphasized the company's strong recovery and ongoing partnerships amid a challenging economic environment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
-
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) has introduced a new test kit to detect Fentanyl in Cocaine and Crack, responding to the urgent need for safety amid rising drug contamination. CEO Amichai Glattstein emphasized the kit's potential life-saving capabilities, highlighting that Fentanyl is often undetectable by sight or taste. Available for purchase online under the brand Touch&Know, the kit offers quick results at an affordable price. IDenta is recognized for its leading role in developing diagnostic kits for drugs and explosives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
News
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) will hold its 2022 Annual Shareholders' meeting on June 26, 2022, at 7:00 PM (GMT +3) in Jerusalem, Israel. The company specializes in developing Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives, and Forensic Products targeting Homeland Security and Consumer Markets. CEO Amichai Glattstein expressed enthusiasm for the upcoming meeting, looking forward to engaging with shareholders. The company is known for its innovative products, which adhere to the stringent standards of law enforcement and security agencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) announced a promotional campaign for its Touch&Know drug and fentanyl detection kits on American Airlines flights, reaching approximately 80,000 flights in May 2022. The CEO emphasized the importance of accessibility to quality products that can save lives. The Touch&Know kits are available for purchase on the company’s website and Amazon throughout the U.S. IDenta Corp. is recognized as a leader in developing testing kits for narcotics and explosives in the homeland security and consumer markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA), a leader in developing drug and explosive detection kits, has secured a contract to supply drug test kits to Italy's security forces. The contract follows extensive product testing, demonstrating IDenta's superior technology and pricing compared to competitors. CEO Amichai Glattstein emphasized this achievement as a significant milestone for international expansion, noting Italy's vital role in drug detection efforts. IDenta aims to enhance operations in more countries, providing innovative solutions for a safer future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) has been awarded a significant contract to supply 220,000 drug test kits to Italy's security forces after extensive testing proved their products' superiority. CEO Amichai Glattstein emphasized the importance of this achievement and the company's ongoing expansion into international markets. IDenta continues to innovate and provide advanced solutions in the drug detection sector, enhancing its competitive edge in technology and pricing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) reported its 2021 annual financial results, showing profitability amidst global challenges from the COVID pandemic. Revenue decreased by 4% to $1,392,136, while gross profit rose 12% to $1,065,965. Operating profit fell 39% to $214,151 due to new operations in the US and increased labor costs. Net profit also declined by 80% to $69,183, impacted by currency exchange rates and unforeseen tax payments. Cash and equivalents decreased to $347,151. Despite challenges, the company seeks new sales avenues and market entry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.67%
Tags
none

FAQ

What is the current stock price of IDenta (IDTA)?

IDenta (IDTA) last closed at $0.2300.

What is the market cap of IDenta (IDTA)?

The market cap of IDenta (IDTA) is approximately $1.0M.